GalNAc Antibodies

Santa Cruz Biotechnology features a diverse variety of GalNAc Antibodies for research in glycoprotein biology. GalNAc Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GalNAc, or N-acetylgalactosamine, plays a crucial role in the glycosylation of proteins and lipids, influencing cell signaling, immune response, and cellular interactions. The significance of GalNAc is evident in various biological processes, including development, cancer progression, and pathogen recognition. Understanding GalNAc function advances therapeutic strategies and biomarker discovery. Researchers worldwide rely on GalNAc monoclonal antibodies to investigate glycosylation patterns in different cell types and tissues. Advanced research techniques incorporating GalNAc monoclonal antibodies help reveal new insights into disease mechanisms and potential treatments. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to glycobiology research and therapeutic development.